Histological changes associated with pyloric and pseudopyloric metaplasia after Helicobacter pylori eradication.
Biopsy
Cell Differentiation
Chronic Disease
Gastric Mucosa
/ chemistry
Gastritis
/ drug therapy
Helicobacter Infections
/ drug therapy
Helicobacter pylori
/ drug effects
Humans
Intercellular Signaling Peptides and Proteins
/ administration & dosage
Metaplasia
Retrospective Studies
Time Factors
Treatment Outcome
Helicobacter pylori
Pseudopyloric metaplasia
Pyloric metaplasia
Spasmolytic polypeptide-expressing metaplasia (SPEM)
Journal
Virchows Archiv : an international journal of pathology
ISSN: 1432-2307
Titre abrégé: Virchows Arch
Pays: Germany
ID NLM: 9423843
Informations de publication
Date de publication:
Oct 2020
Oct 2020
Historique:
received:
19
12
2019
accepted:
25
03
2020
revised:
04
03
2020
pubmed:
2
5
2020
medline:
8
10
2020
entrez:
2
5
2020
Statut:
ppublish
Résumé
Pyloric metaplasia (PM) and pseudopyloric metaplasia (PPM) are metaplastic changes resulting in pyloric-type glands in the gastric oxyntic mucosa that mainly occur in chronic gastritis caused by Helicobacter pylori (H. pylori) infection. Focusing on PM and PPM, we classified the histological changes in gastric mucosa according to the Updated Sydney System, using 314 biopsy specimens of gastric greater curvature of the middle body before H. pylori eradication (HPE). Next, the numbers of PM and PPM glands were counted in 47 specimens, and subjects were followed up over 10 years after HPE. PPM was recognized jointly with inflammation, activity, atrophy, and intestinal metaplasia, but PM was recognized more frequently than PPM as atrophy and intestinal metaplasia progressed. Both PM and PPM regressed significantly within 6 years after HPE. Additionally, we demonstrated that PM and PPM are not always coincident with spasmolytic polypeptide-expressing metaplasia (SPEM). In conclusion, PM and PPM are considered different modulations of the same line of differentiation, which are both reversible, with PM potentially emerging from PPM upon progression.
Identifiants
pubmed: 32356024
doi: 10.1007/s00428-020-02805-9
pii: 10.1007/s00428-020-02805-9
doi:
Substances chimiques
Intercellular Signaling Peptides and Proteins
0
spasmolytic polypeptide
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
489-496Commentaires et corrections
Type : CommentIn